CHRONIC SPONTANEOUS URTICARIA (CSU)
Clinical trials for CHRONIC SPONTANEOUS URTICARIA (CSU) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA (CSU) trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA (CSU), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection tested for people with Hard-to-Treat chronic hives
Disease control Not yet recruitingThis study is testing whether an investigational injection called CM512 can help reduce the severity of hives and itching in adults with chronic spontaneous urticaria (CSU) who still have symptoms despite taking standard allergy medications. Participants will be randomly assigned…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Apr 04, 2026 00:51 UTC
-
New hope for stubborn hives that Won't quit
Disease control Not yet recruitingThis study is testing an investigational drug called ICP-332 for adults with moderate to severe chronic hives that are not controlled by standard allergy medicines. The main goal is to see if the drug can safely reduce hive symptoms and itching over several weeks. Participants wi…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE2, PHASE3 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
New drug trial offers hope for people with uncontrollable chronic hives
Disease control Not yet recruitingThis study is testing whether a new drug called lesigercept can help adults with chronic spontaneous urticaria (long-lasting hives with no clear cause) when standard antihistamine medicines don't work well enough. About 150 participants will receive either lesigercept or a placeb…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA (CSU)
Phase: PHASE2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC